Louis Kuritzky, MD

Peer Reviewed
Peer Reviewed
04/05/2016
Michael J. Bloch, MD; Louis Kuritzky, MD
As chronic kidney disease progresses, patients may present with comorbidities such as hypertension, cardiovascular disease, dyslipidemia, and anemia.
04/05/2016
Hypertension
Hypertension
02/25/2014
Jeffrey P. Levine, MD, MPH; Martha M. Funnell, MS, RN, CMD; Louis Kuritzky, MD
More than 30% of adults in the United States have hypertension, although more of the cases are uncontrolled than are controlled.
02/25/2014
08/10/2015
Louis Kuritzky, MD; David M. Quillen, MD
This article presents a series of hypothetical case studies that represent some of the more common therapeutic dilemmas that primary care clinicians face in their daily management of patients with T2DM. ...
08/10/2015
Atrial Fibrillation
Atrial Fibrillation
02/20/2014
Louis Kuritzky, MD; Eric A. Dietrich, PharmD, BCPS
The advent of a variety of methodologically new antithrombotic agents has provided clinicians with important choices to make when selecting treatments for commonplace syndromes, such as atrial...
02/20/2014
Warfarin
Warfarin
02/24/2015
Louis Kuritzky, MD; Eric A. Dietrich, PharmD, BCPS
For 65 years, warfarin has been widely used as an effective medication in the prevention of venous thromboembolism for a variety of disease states, including atrial fibrillation, as well as for the...
02/24/2015
acne
acne
02/18/2014
Louis Kuritzky, MD; Kristin Steffes, MD; David Wymer
This article provides an overview of acne vulgaris, with a focus on inflammatory and post-adolescent acne, and outlines a framework that primary care physicians can use to effectively treat these patients. ...
02/18/2014
coumadin
coumadin
10/21/2014
Louis Kuritzky, MD; Eric A. Dietrich, PharmD, BCPS
LH is a 60-year-old white male with a 10-year history of longstanding hypertension as well as systolic heart failure (sys-HF) with a reduced ejection fraction (EF) of 20%.
10/21/2014
deep venous thrombosis
deep venous thrombosis
09/05/2014
Eric A. Dietrich, PharmD, BCPS; Louis Kuritzky, MD
As with the decision to initiate or continue warfarin therapy, decisions surrounding bridge therapy are patient-specific and should be evaluated on a case-by-case basis.
09/05/2014
coumadin
coumadin
08/06/2014
Louis Kuritzky, MD; Eric A. Dietrich, PharmD, BCPS
We have recently been following KD, a 58-year-old male who was diagnosed with a first unprovoked deep vein thrombosis (DVT). After completing 3 months of treatment with warfarin, KD elected to continue...
08/06/2014
Warfarin
Warfarin
07/08/2014
Louis Kuritzky, MD; Eric A. Dietrich, PharmD, BCPS
Unprovoked DVT is a term used to describe the occurrence of DVT in the absence of currently recognized triggers, such as surgery, long-haul travel, immobilization, or trauma.
07/08/2014